Hypertension Clinical Trial
— ISOPRESSOfficial title:
Effect of Isometric Handgrip Training on Ambulatory Blood Pressure: a Multi-center Study
Meta-analysis studies have demonstrated that isometric training with handgrip promotes reductions in clinical blood pressure, reaching 8 mmHg for systolic blood pressure and 4 mmHg for diastolic. However, the effects of this training modality on ambulatory blood pressure, which is better discriminant of cardiovascular risk than clinical BP, remains uncertain. Thus, the ISOPRESS Network, consists of researchers from Brazilian institutions of education and research (Federal University of Santa Catarina, Federal University of Amazonas, Federal University of Sergipe, Federal Rural University of Pernambuco and Universidade Nove de Julho), will conduct a multi-center study to analyze the effects of isometric handgrip training on clinic and 24-h ambulatory blood pressure in patients with hypertension. For this, each research center will conduct a randomized controlled trial with medicated patients with hypertension, of both sex. The participants will be randomized into two groups: isometric handgrip training group (HBT: n = 25 per center) and control group (CG: n = 25 per center).Subjects assigned to the HBT will train three times per week, four sets of 2-min isometric contractions (using alternate hands) at 30% of maximal voluntary contraction, during 24 weeks. Subjects randomized to the CG will perform stretching and relaxation exercises three times per week, during 24 weeks. The evaluations will occur in three moments: baseline, post-12 and post-24 weeks. The primary outcome will be ambulatory blood pressure, while clinic blood pressure and cardiac autonomic modulation will be analyzed as secondary outcomes. For data analysis, in addition to descriptive statistics, two-way ANOVA for mixed model will be applied for within and between groups comparison. The level of significance that will be adopted is p<0.05.
| Status | Recruiting |
| Enrollment | 250 |
| Est. completion date | December 15, 2024 |
| Est. primary completion date | July 15, 2024 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility | Inclusion Criteria: - Diagnosis of hypertension, controlled by up to three antihypertensive medications - Blood pressure levels between 130 and 180 mmHg - No high cardiovascular risk (no other cardiovascular, metabolic or pulmonary disease nor any signals or symptoms of these disease) - Not engaged in a physical exercise program for at least six months - Not present cognitive impairment (Montreal Cognitive Assessment = 26 points) Exclusion Criteria: - Adherence to less than 85% of training sessions - Diagnosis of other cardiovascular diseases or diabetes during the course of the study - Adherence to another supervised physical exercise program - Change in medication class and/ or dose during the study - Aggravation of the disease (i.e. blood pressure above 180 or use of four or more medications). |
| Country | Name | City | State |
|---|---|---|---|
| Brazil | Federal University of Sergipe | Aracaju | |
| Brazil | Universidade Federal de Santa Catarina | Florianopolis | Santa Catarina |
| Brazil | Federal University of Amazonas | Parintins | |
| Brazil | Federal Rural University of Pernambuco | Recife | |
| Brazil | Universidade Nove de Julho | São Paulo |
| Lead Sponsor | Collaborator |
|---|---|
| Universidade Federal de Santa Catarina | Conselho Nacional de Desenvolvimento Científico e Tecnológico |
Brazil,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in ambulatory systolic blood pressure | 24h-ambulatory blood pressure monitoring | Baseline, 12 weeks 24 weeks | |
| Primary | Change in ambulatory diastolic blood pressure | 24h-ambulatory blood pressure monitoring | Baseline, 12 weeks 24 weeks | |
| Primary | Change in ambulatory mean blood pressure | 24h-ambulatory blood pressure monitoring | Baseline, 12 weeks 24 weeks | |
| Secondary | Change in clinic systolic blood pressure | Clinic blood pressure will be checked using an automatic instrument | Baseline, 12 weeks 24 weeks | |
| Secondary | Change in clinic diastolic blood pressure | Clinic blood pressure will be checked using an automatic instrument | Baseline, 12 weeks 24 weeks | |
| Secondary | Change in clinic mean blood pressure | Clinic blood pressure will be checked using an automatic instrument | Baseline, 12 weeks 24 weeks | |
| Secondary | Change in heart rate variability | For heart rate variability assessment, R-R interval will be obtained using a heart rate monitor (POLAR, RS 800CX), following the recommendations of the Task Force of the European Society of Cardiology and the North American. | Baseline, 12 weeks 24 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |